Redhill Biopharm

RDHL NASDAQ
6.87
+0.18
+2.61%
已收盘, 16:00 08/16 EDT
开盘
6.74
昨收
6.70
最高
6.93
最低
6.74
成交量
2.24万
成交均量(3M)
7.29万
52周最高
9.57
52周最低
5.13
换手率
1.05%
市值
1,466.27万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Redhill Biopharm RDHL股票价格,Redhill Biopharm股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Redhill Biopharma Ltd, is an Israel-based specialty biopharmaceutical company. The Company focuses on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. It offers the following gastrointestinal products in the United States: Donnatal, a prescription oral adjunctive drug used in the treatment of Irritable Bowel Syndrome (IBS) and acute enterocolitis, as well as EnteraGam, a medical food intended for the dietary management, under medical supervision, of chronic diarrhea and loose stools. Its clinical-stage pipeline includes: TALICIA (RHB-105), an oral combination therapy for the treatment of Helicobacter pylori infection; RHB-104, an oral combination therapy for the treatment of Crohn's disease; BEKINDA (RHB-102), a once-daily oral pill formulation of ondansetron; RHB-106; YELIVA (ABC294640); MESUPRON, and RIZAPORT (RHB-103).
展开 >

最近浏览

名称
价格
涨跌幅